Neuroimmunology

Group leader

Publications (139)

Brieva, L; Estruch, BC; Merino, JAG; Meca-Lallana, V; Rio, J; Rodriguez-Antigueedad, A; Aguera, E; Ara, JR; Luque, AA; Garcia, CA; Blanco, Y; Castillo-Trivino, T; Costa-Frossard, L; Platas, MG; Pascual, LL; Llaneza-Gonzalez, M; Gines, MLM; Matias-Guiu, J; Meca-Lallana, JE; Bilbao, MM; Sempere, AP; Romero-Pinel, L; Saiz, A; Moral, E

Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

Multiple Sclerosis and Related Disorders 63 -. 01/07/2022.

[doi:10.1016/j.msard.2022.103805]

Vermersch P; Brieva-Ruiz L; Fox RJ; Paul F; Ramio-Torrenta L; Schwab M; Moussy A; Mansfield C; Hermine O; Maciejowski M

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.

Neurology-Neuroimmunology & Neuroinflammation 9 -. 01/05/2022.

[doi:10.1212/NXI.0000000000001148]

Sancho-Saldaña, A; Gil Sánchez A; Quirant-Sánchez, B; Nogueras, L; Peralta, S; Solana, MJ; González-Mingot, C; Gallego, Y; Quibus, L; Ramo-Tello, C; Presas-Rodríguez, S; Martínez-Cáceres, E; Torres, P; Hervas, JV; Valls, J; Brieva, L

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.

Journal of Clinical Medicine 11 -. 29/04/2022.

[doi:10.3390/jcm11092509]

Fernández-Velasco JI; Monreal E; Kuhle J; Meca-Lallana V; Meca-Lallana J; Izquierdo G; Oreja-Guevara C; Gascón-Giménez F; Sainz de la Maza S; Walo-Delgado PE; Lapuente-Suanzes P; Maceski A; Rodríguez-Martín E; Roldán E; Villarrubia N; Saiz A; Blanco Y; Diaz-Pérez C; Valero-López G; Diaz-Diaz J; Aladro Y; Brieva L; Íñiguez C; González-Suárez I; Rodríguez de Antonio LA; García-Domínguez JM; Sabin J; Llufriu S; Masjuan J; Costa-Frossard L; Villar LM

Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.

Frontiers in Immunology 13 842354-842354. 21/03/2022.

[doi:10.3389/fimmu.2022.842354]

de la Maza, SS; Maurino, J; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco, MR; García-Soto, JD; del Campo-Amigo, M; Navarro-Cantó, L; Agüera, E; Garcés, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervás, M; de Alda, LR; Gómez-Ballesteros, R; Castillo-Triviño, T

Measuring productivity loss in early relapsing-remitting multiple sclerosis

Multiple Sclerosis and Related Disorders 58 -. 01/02/2022.

[doi:10.1016/j.msard.2021.103398]

Ramo-Tello C; Blanco Y; Brieva L; Casanova B; Martínez-Cáceres E; Ontaneda D; Ramió-Torrentá L; Rovira À

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.

Journal of Personalized Medicine 12 -. 22/12/2021.

[doi:10.3390/jpm12010006]

Granell-Geli, J; Izquierdo-Gracia, C; Selles-Rius, A; Teniente-Serra, A; Presas-Rodriguez, S; Mansilla, MJ; Brieva, L; Sotoca, J; Mane-Martinez, MA; Moral, E; Bragado, I; Goelz, S; Martinez-Caceres, E; Ramo-Tello, C

Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab

Journal of Personalized Medicine 11 -. 01/12/2021.

[doi:10.3390/jpm11121347]

Munoz-Lopetegi, A; Pujol, M; Giménez, M; Gaig, C; Brieva, L; Santamaria, J

Abnormal sleep behavior caused by hypoglycemia

SLEEP MEDICINE 85 268-270. 01/09/2021.

[doi:10.1016/j.sleep.2021.07.029]

Jorge C; Cetó M; Arias A; Blasco E; Gil MP; López R; Dakterzada F; Purroy F; Piñol-Ripoll G

Level of understanding of Alzheimer disease among caregivers and the general population.

NEUROLOGIA 36 426-432. 01/07/2021.

[doi:10.1016/j.nrleng.2018.03.004]

Meca-Lallana, J; García-Merino, JA; Martínez-Yélamos, S; Vidal-Jordana, A; Costa, L; Eichau, S; Rovira À; Brieva, L; Agüera, E; Zarranz, ARA

Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.

Neurodegenerative Disease Management 11 251-261. 01/06/2021.

[doi:10.2217/nmt-2020-0049]

Sanchez-Cazalilla, Marta; Gonzalez-Mingot, Cristina; Torterolo, Giovanni; Torrent, Aurora; Batalla, Iolanda

Episodic Ataxia Misdiagnosed as Anxiety Disorder.

The Primary Care Companion For Cns Disorders 23 -. 22/04/2021.

[doi:10.4088/PCC.20l02730]

Maurino J; Sotoca J; Sempere ÁP; Brieva L; López de Silanes C; Caminero AB; Terzaghi M; Gracia-Gil J; Saposnik G

High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.

Patient-Patient Centered Outcomes Research 14 241-248. 01/03/2021.

[doi:10.1007/s40271-020-00454-3]